<?xml version="1.0" encoding="UTF-8"?>
<ref id="B14">
 <label>14.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Bloes</surname>
    <given-names>DA</given-names>
   </name>, 
   <name name-style="western">
    <surname>Haasbach</surname>
    <given-names>E</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hartmayer</surname>
    <given-names>C</given-names>
   </name>, 
   <name name-style="western">
    <surname>Hertlein</surname>
    <given-names>T</given-names>
   </name>, 
   <name name-style="western">
    <surname>Klingel</surname>
    <given-names>K</given-names>
   </name>, 
   <name name-style="western">
    <surname>Kretschmer</surname>
    <given-names>D</given-names>
   </name>, 
   <name name-style="western">
    <surname>Planz</surname>
    <given-names>O</given-names>
   </name>, 
   <name name-style="western">
    <surname>Peschel</surname>
    <given-names>A</given-names>
   </name>
  </person-group>
  <year>2017</year>
  <article-title>Phenol-soluble modulin peptides contribute to influenza A virus-associated 
   <italic>Staphylococcus aureus</italic> pneumonia
  </article-title>. 
  <source>Infect Immun</source>
  <volume>85</volume>:
  <elocation-id>e00620-17</elocation-id>. doi:
  <pub-id pub-id-type="doi">10.1128/IAI.00620-17</pub-id>.
 </mixed-citation>
</ref>
